2024
DOI: 10.4251/wjgo.v16.i11.4392
|View full text |Cite
|
Sign up to set email alerts
|

Drug-eluting beads chemoembolization combined with programmed cell death 1 inhibitor and lenvatinib for large hepatocellular carcinoma

Hui Yang,
Guang-Ping Qiu,
Jie Liu
et al.

Abstract: BACKGROUND The combination of transarterial chemoembolization (TACE), lenvatinib, and programmed cell death 1 (PD-1) inhibitor has been widely used in the treatment of advanced hepatocellular carcinoma (HCC) and has achieved promising results. However, there are few studies comparing whether drug-eluting beads TACE (D-TACE) can bring more survival benefits to patients with large HCC compared to conventional TACE (C-TACE) in this triplet therapy. AIM To compare the efficacy and adv… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Publication Types

Select...

Relationship

0
0

Authors

Journals

citations
Cited by 0 publications
references
References 36 publications
0
0
0
Order By: Relevance

No citations

Set email alert for when this publication receives citations?